TY - JOUR JF - MJIRI JO - Med J Islam Repub Iran VL - 33 IS - 1 PY - 2019 Y1 - 2019/2/01 TI - Comparison of serum levels of asymmetric dimethylarginine between patients who take two types of atypical anti psychotics TT - N2 - Background: Schizophrenia is associated with increased cardiovascular morbidity. Asymmetric dimethylarginine (ADMA) has been suggested as a cardiovascular biomarker. Treatment with atypical antipsychotics can increase some traditional risk factors of coronary artery disease. In addition to traditional risk factors, this study is carried out as a comparison of serum levels of ADMA and non-traditional factors among patients who take two types of atypical antipsychotics. Methods: In this clinical study, 57 schizophrenic patients with multiple episodes and 20 healthy voluntaries that fulfilled inclusion and exclusion criteria were entered into the study. The patients were divided into 3 groups (18 patients received risperidone alone, 20 patients received clozapine alone and 19 patients did not receive any drug). Plasma concentrations of ADMA, high-sensitivity C-reactive protein (hs-CRP) and homocysteine were measured through enzyme-linked immunosorbent assay (ELISA), and traditional risk factors of metabolic syndrome were measured. Results: Mean age of participants was 46.08±12.54 years. Moreover, the traditional (High-density lipoprotein (HDL), total cholesterol, waistline, and Body Mass Index (BMI)) and non-traditional factors (Homocysteine, hs-CRP) and ADMA were higher in patients with schizophrenia compared to healthy group (p≤ 0.05). Also, in the clozapine group, all mentioned non-traditional factors and ADMA were significantly higher than other groups (p≤ 0.05). Conclusion: In the clozapine group, levels of non-traditional factors and ADMA were significantly higher which indicates these patients are at risk of cardiovascular disease. SP - 682 EP - 686 AU - Safaei, Maryam AU - Akhondpoor Manteghi, Ali AU - Shahini, Najmeh AU - Mohammadpour, Amir Hooshang AD - Pharmaceutical Instiute of Technology, Pharmaceutical Research Center & Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran KW - Asymmetric dimethylarginine KW - Atypical antipsychotics KW - Metabolic syndrome KW - Schizophrenia UR - http://mjiri.iums.ac.ir/article-1-4115-en.html DO - 10.47176/mjiri.33.114 ER -